| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |